NKE
NIKE, Inc.
NKE has lower modeled downside risk, despite its lower overall score.
RH
Rh
RH has a slight edge over NKE overall, supported by stronger modeled upside.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
RH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
RH's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over RH in the historical PE scenario, which offers more potential upside but is not a forecast.
RH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $80.52 | -38% |
| Forward | 17x | $129 | — |
| Current | 23x | $129 | — |
| Fair | 31x | $174 | +35% |
| Expensive | 59x | $332 | +157% |
Historical ranges are pointers, not guarantees.
RH's PE is in its cheap range at 23x. If earnings grow as analysts expect, today's price would be 17x next year's earnings.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
RH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
RH has the edge over NKE on the outlook, with more favorable valuation and earnings expectations.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
RH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $7.76 | +38% |
| Q3 2026 | $5.62 | +4.3% |
| Q2 2026 | $5.18 | +23% |
| Q1 2026 | $6.31 | +74% |
| Q4 2025 | $5.56 | +46% |
| Q3 2025 | $5.39 | +164% |
| Q2 2025 | $4.22 | +6.8% |
| Q1 2025 | $3.62 | -39% |
| Q4 2024 | $3.82 | -59% |
RH has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
RH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $922.2M | +2.6% |
| Q2 2026 | $800.3M | -1.7% |
| Q1 2026 | $842.6M | +3.7% |
| Q4 2025 | $883.8M | +8.9% |
| Q3 2025 | $899.2M | +8.4% |
| Q2 2025 | $814M | +12% |
| Q4 2024 | $811.7M | +8.1% |
| Q3 2024 | $829.7M | +3.6% |
RH has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 12% | -2.7 points |
| Q2 2026 | 4.3% | -2.6 points |
| Q1 2026 | 11% | +2.8 points |
| Q4 2025 | 12% | -0.5 points |
| Q3 2025 | 14% | +2.7 points |
| Q2 2025 | 6.9% | -0.6 points |
| Q1 2025 | 8.7% | N/A |
| Q4 2024 | 13% | +5.7 points |
RH has the edge over NKE on profitability, with a higher operating margin.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
RH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $99.6M | +23% |
| Q2 2026 | $13.3M | -61% |
| Q1 2026 | $54.6M | +$124.3M |
| Q4 2025 | $83M | +$179M |
| Q3 2025 | $80.7M | +$118.6M |
| Q2 2025 | $34.1M | +$44.2M |
| Q1 2025 | -$69.7M | +$181.8M |
| Q4 2024 | -$96M | -646% |
RH has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
RH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +4.4% | +824K shares |
| 1 year | -0.3% | -68K shares |
| 3 years | -13% | -3.1M shares |
| 5 years | -37% | -11.5M shares |
| Available history | -19% | -4.5M shares |
RH has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q1 2024 | — |
| Q4 2023 | $44.6M |
| Q1 2023 | $713.6M |
| Q4 2022 | $31.7M |
| Q1 2020 | — |
| Q4 2019 | — |
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
RH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.3x | Net Cash |
| Q2 2026 | -0.1x | Net Cash |
| Q1 2026 | -0.1x | Net Cash |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 0.2x | Very low |
RH has the edge over NKE on leverage, with a lower net debt burden relative to earnings.
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
RH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 44.3 | Neutral |
| Stochastic | 30.5 | Neutral |
RH's weekly RSI is 44 (neutral) and its Stochastic is 30 (neutral).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over RH on valuation relative to its sector.
RH PE vs Consumer Cyclical Sector
| Metric | RH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 18x | 28% above |
| PE % | 32 | 47 | 15 pts below |
RH is trading at 23x earnings, a 28% premium to the Consumer Cyclical sector's median of 18x.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
RH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $127.4 | 1.4% above |
| 20 week MA | $148.5 | 13% below |
| 50 week MA | $156.8 | 18% below |
| 100 week MA | $198.9 | 35% below |
| 200 week MA | $243.8 | 47% below |
RH has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 47% below its 200-week average.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.
RH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $214.9 | $475.7 | +121% |
| 2021 | $475.7 | $546.1 | +15% |
| 2022 | $546.1 | $264.4 | -52% |
| 2023 | $264.4 | $291.5 | +10% |
| 2024 | $291.5 | $398.1 | +37% |
| 2025 | $398.1 | $185.7 | -53% |
| 2026 YTD | $185.7 | $129.2 | -30% |
RH has the edge over NKE on returns for 2026, with the stronger performance.